Previous Close | 57.57 |
Open | 58.28 |
Bid | 56.25 x 800 |
Ask | 58.40 x 900 |
Day's Range | 55.56 - 58.40 |
52 Week Range | 52.43 - 72.11 |
Volume | |
Avg. Volume | 1,128,422 |
Market Cap | 8.113B |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | 10.60 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.32 (0.56%) |
Ex-Dividend Date | May 13, 2022 |
1y Target Est | N/A |
ST. PETERSBURG, Fla., May 18, 2022--Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), announces the launch of the Qfinity™ autoinjector platform, a simple, reusable and modular solution for subcutaneous (SC) drug self-administration, at a lower cost than market alternatives — supporting the emerging prioritization of sustainable drug delivery within the pharmaceutical industry.
ST. PETERSBURG, Fla., May 17, 2022--Jabil Inc. (NYSE: JBL) today launched PK 5000, an eco-friendly, powder-based additive material engineered to deliver improved strength, chemical resistance and resilience in comparison to general-purpose nylon materials, such as PA 12. This patent-pending material has been formulated to support highly demanding automotive, consumer electronics, defense, medical and industrial manufacturing applications. Jabil will showcase a variety of parts produced using PK
ST. PETERSBURG, Fla., April 27, 2022--Jabil (NYSE: JBL) today announced the next step in its manufacturing and supply chain collaboration with ams OSRAM, a global leader in optical solutions, with the development of a lateral flow testing platform. The COVID-19 pandemic brought the topic of testing to the forefront, validating the importance of reliable and robust lab-quality testing that can be conducted remotely and with fast turnaround times. With the role of testing only increasing in the fu